Kezar Life Sciences Inc (KZR)

Official site

BIOTECHNOLOGY

$7.29

+0.00 (+0.00%)

Last updated: May 11, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

69%(22/32)

Avg Surprise

-42.36%

Streak

2 Q

Upcoming Estimates

Period ending Jun 30, 2026

EPS Consensus$-0.91

Range$-0.91 - $-0.91

1 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$-1.25+27.5%

60d ago$-1.25+27.5%

30d ago$-1.25+27.5%

7d ago$-0.910.0%

Current$-0.91

Revenue Consensus

Range$0 - $0

3 analysts

Period ending Sep 30, 2026

EPS Consensus$-0.87

Range$-0.87 - $-0.87

1 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$-1.24+29.6%

60d ago$-1.24+29.6%

30d ago$-1.24+29.6%

7d ago$-0.870.0%

Current$-0.87

Revenue Consensus

Range$0 - $0

3 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-1.26	$-1.70 - $-0.82	-	-	2	-	-
Sep 30, 2026Sep 26EST	-	$-0.87	$-0.87 - $-0.87	-	-	1	1 0 30d	-
Jun 30, 2026Jun 26EST	-	$-0.91	$-0.91 - $-0.91	-	-	1	1 0 30d	-
Mar 31, 2026Mar 26 Reported May 11, 2026Reported May 11	$-0.70	$-0.98	$-0.98 - $-0.98	+28.53%	Beat	1	1 0 30d	+65.0%
Dec 31, 2025Dec 25 Reported Mar 27, 2026Reported Mar 27	$-1.05	$-1.31	$-1.48 - $-1.14	+19.57%	Beat	2	1 0 30d	+64.9%
Sep 30, 2025Sep 25 Reported Nov 12, 2025Reported Nov 12	$-1.53	$-0.26	$-0.49 - $0.01	-488.46%	Miss	3	2 0 30d	+45.0%
Jun 30, 2025Jun 25 Reported Aug 13, 2025Reported Aug 13	$-1.87	$-0.28	$-0.53 - $0.00	-567.86%	Miss	5	2 0 30d	-592.6%
Mar 31, 2025Mar 25 Reported May 13, 2025Reported May 13	$-2.00	$-2.65	$-2.80 - $-2.43	+24.53%	Beat	4	0 1 30d	-566.7%
Dec 31, 2024Dec 24 Reported Mar 25, 2025Reported Mar 25	$-3.00	$-2.76	$-2.78 - $-2.74	-8.70%	Miss	2	0 1 30d	-581.8%
Sep 30, 2024Sep 24 Reported Nov 12, 2024Reported Nov 12	$-2.78	$-3.15	$-3.80 - $-2.30	+11.75%	Beat	6	No revisions (30d)	-768.8%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$-0.27	$-0.32	$-0.36 - $-0.26	+15.63%	Beat	5	No revisions (30d)	+20.6%
Mar 31, 2024Mar 24 Reported May 9, 2024Reported May 9	$-0.30	$-0.33	$-0.41 - $-0.25	+9.09%	Beat	6	No revisions (30d)	+3.2%
Dec 31, 2023Dec 23 Reported Mar 14, 2024Reported Mar 14	$-0.44	$-0.38	$-0.43 - $-0.34	-15.79%	Miss	5	No revisions (30d)	-76.0%
Sep 30, 2023Sep 23 Reported Nov 13, 2023Reported Nov 13	$-0.32	$-0.35	$-0.37 - $-0.31	+8.57%	Beat	6	No revisions (30d)	-28.0%
Jun 30, 2023Jun 23 Reported Aug 10, 2023Reported Aug 10	$-0.34	$-0.32	$-0.34 - $-0.28	-6.25%	Miss	6	No revisions (30d)	-36.0%
Mar 31, 2023Mar 23 Reported May 11, 2023Reported May 11	$-0.31	$-0.29	$-0.31 - $-0.26	-6.90%	Miss	6	No revisions (30d)	-19.2%
Dec 31, 2022Dec 22 Reported Mar 14, 2023Reported Mar 14	$-0.25	$-0.28	$-0.29 - $-0.24	+10.71%	Beat	6	No revisions (30d)	+0.0%
Sep 30, 2022Sep 22 Reported Nov 10, 2022Reported Nov 10	$-0.25	$-0.27	$-0.32 - $-0.25	+7.41%	Beat	6	No revisions (30d)	+10.7%
Jun 30, 2022Jun 22 Reported Aug 11, 2022Reported Aug 11	$-0.25	$-0.27	$-0.29 - $-0.24	+7.41%	Beat	6	1 0 30d	+0.0%
Mar 31, 2022Mar 22 Reported May 12, 2022Reported May 12	$-0.26	$-0.28	$-0.31 - $-0.26	+7.14%	Beat	6	2 1 30d	-4.0%
Dec 31, 2021Dec 21 Reported Mar 17, 2022Reported Mar 17	$-0.25	$-0.30	$-0.33 - $-0.27	+16.67%	Beat	6	1 0 30d	-13.6%
Sep 30, 2021Sep 21 Reported Nov 9, 2021Reported Nov 9	$-0.28	$-0.26	$-0.28 - $-0.26	-7.69%	Miss	6	No revisions (30d)	-21.7%
Jun 30, 2021Jun 21 Reported Aug 12, 2021Reported Aug 12	$-0.25	$-0.26	$-0.27 - $-0.25	+3.85%	Beat	6	No revisions (30d)	-13.6%
Mar 31, 2021Mar 21 Reported May 12, 2021Reported May 12	$-0.25	$-0.24	$-0.25 - $-0.22	-4.17%	Miss	5	No revisions (30d)	+16.7%
Dec 31, 2020Dec 20 Reported Mar 11, 2021Reported Mar 11	$-0.22	$-0.23	$-0.25 - $-0.20	+4.35%	Beat	5	No revisions (30d)	+56.0%
Sep 30, 2020Sep 20 Reported Nov 5, 2020Reported Nov 5	$-0.23	$-0.21	$-0.22 - $-0.19	-9.52%	Miss	5	No revisions (30d)	+52.1%
Jun 30, 2020Jun 20 Reported Aug 5, 2020Reported Aug 5	$-0.22	$-0.26	$-0.28 - $-0.24	+15.38%	Beat	5	No revisions (30d)	+52.2%
Mar 31, 2020Mar 20 Reported May 7, 2020Reported May 7	$-0.30	$-0.37	$-0.53 - $-0.26	+18.92%	Beat	4	No revisions (30d)	+25.0%
Dec 31, 2019Dec 19 Reported Mar 12, 2020Reported Mar 12	$-0.50	$-0.54	$-0.58 - $-0.49	+7.41%	Beat	5	No revisions (30d)	-66.7%
Sep 30, 2019Sep 19 Reported Nov 6, 2019Reported Nov 6	$-0.48	$-0.51	$-0.55 - $-0.49	+5.88%	Beat	5	No revisions (30d)	-60.0%
Jun 30, 2019Jun 19 Reported Aug 7, 2019Reported Aug 7	$-0.46	$-0.48	$-0.53 - $-0.44	+4.17%	Beat	5	No revisions (30d)	+86.1%
Mar 31, 2019Mar 19 Reported May 7, 2019Reported May 7	$-0.40	$-0.40	$-0.52 - $-0.32	+0.00%	Beat	4	No revisions (30d)	+91.4%
Dec 31, 2018Dec 18 Reported Mar 26, 2019Reported Mar 26	$-0.30	$-0.44	$-0.63 - $-0.35	+31.82%	Beat	4	No revisions (30d)	-1600.0%
Sep 30, 2018Sep 18 Reported Nov 8, 2018Reported Nov 8	$-0.30	$-0.48	$-0.62 - $-0.40	+37.50%	Beat	4	No revisions (30d)	-
Jun 30, 2018Jun 18 Reported Aug 9, 2018Reported Aug 9	$-3.31	$-0.52	$-0.65 - $-0.46	-536.54%	Miss	4	No revisions (30d)	-
Mar 31, 2018Mar 18 Reported May 24, 2018Reported May 24	$-4.67	$0.00	-	N/A	Miss	-	-	-
Dec 31, 2017Dec 17 Reported Mar 30, 2018Reported Mar 30	$0.02	$0.00	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	N/A
Current Ratio	N/A	Quick Ratio	N/A
Trading Statistics
Beta	N/A	Avg Volume	N/A
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$7.33

SMA 20$7.32

SMA 50$7.13

SMA 200$5.81

EMA 10$7.32

EMA 20$7.30

EMA 50$7.10

EMA 200$6.11

MACD

Line: 0.06Signal: 0.08Hist: -0.02

ADX

ADX: 29.3+DI: 23.0-DI: 14.4

Aroon & PSAR

Aroon Up32.0

Aroon Down40.0

PSAR$6.73

Bollinger Bands

Upper Band$7.40

Lower Band$7.25

%B Position206%(Upper)

Band Width0.27

RSI (14-Day)

Neutral

52.5

Momentum Oscillators

Stoch %K37.5

Stoch %D49.7

Williams %R-75.0

ROC (10d)N/A

MomentumN/A

CCI (20d)-88.9

MFI (14d)36.4

Volatility Measures

ATR (14d)$0.13(1.8%)

StdDev (20d)0.04

Hist Vol8.3%(Low)

Volume Flow

VWAP$7.29

OBV3.9M

AD Line3.2M

CMF (20d)-0.428

Volume Metrics

Avg Vol (20d)125.2K

Vol RatioN/A

VWMA (20d)$7.33

Pivot Points

R3$7.62

R2$7.54

R1$7.42

Pivot Point$7.34

S1$7.22

S2$7.14

S3$7.02

Advanced Oscillators

TSI14.14

Ultimate Osc41.9

KST33.35

Financial Data

Quarter	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Revenue	$0	$0	$0	$0	$0	$1.04M	$0	$0	$0	$-5,428,000	$7.00M	$0
Cost of Revenue	$0	$176,000	$0	$0	$0	$259,000	$0	$0	$0	$280,000	$0	$0
Gross Profit	$0	$-176,000	$0	$0	$0	$521,000	$0	$0	$0	$-280,000	$7.00M	$0

Operating Expenses	$7.37M	$15.16M	$11.71M	$14.60M	$17.63M	$21.56M	$21.95M	$23.38M	$23.71M	$34.59M	$32.53M	$26.78M
R&D	$1.54M	$5.08M	$6.91M	$9.58M	$12.18M	$16.03M	$16.24M	$16.30M	$17.17M	$22.64M	$23.74M	$21.00M
SG&A	$5.21M	$2.71M	$5.34M	$5.02M	$5.45M	$5.14M	$6.11M	$5.60M	$6.54M	$5.76M	$8.79M	$5.79M
Operating Income	$-7,365,000	$-15,164,000	$-11,715,000	$-14,599,000	$-17,629,000	$-21,563,000	$-21,948,000	$-23,383,000	$-23,711,000	$-34,589,000	$-25,527,000	$-26,784,000

Interest Income	$609,000	$801,000	$1.03M	$1.20M	$1.42M	$1.73M	$2.04M	$2.24M	$2.45M	$2.73M	$2.82M	$2.86M
Interest Expense	$0	$0	$0	$302,000	$347,000	$0	$0	$401,000	$400,000	$0	$396,000	$385,000
Income Before Tax	$-5,756,000	$-14,546,000	$-11,227,000	$-13,704,000	$-16,556,000	$-20,218,000	$-20,313,000	$-21,547,000	$-21,658,000	$-32,260,000	$-23,103,000	$-24,308,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-5,756,000	$-14,546,000	$-11,227,000	$-13,704,000	$-16,556,000	$-20,218,000	$-20,313,000	$-21,547,000	$-21,658,000	$-32,260,000	$-23,103,000	$-24,308,000

EBITDA	$-6,318,000	$-15,283,000	$-11,945,000	$-14,901,000	$-17,907,000	$-22,153,000	$-22,850,000	$-24,446,000	$-24,900,000	$-35,782,000	$-26,957,000	$-28,295,000
EBIT	$-6,365,000	$-15,164,000	$-11,715,000	$-14,599,000	$-17,629,000	$-21,563,000	$-21,948,000	$-23,383,000	$-23,711,000	$-34,589,000	$-25,527,000	$-26,784,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about KZR

News

Articles from Enodia Therapeutics and Kezar Life Sciences, Inc.

Enodia Therapeutics has acquired preclinical assets from Kezar Life Sciences' Sec61-based discovery and development program. This acquisition will strengthen Enodia's Sec61 portfolio by enhancing its understanding...

FinancialContent•Jul 31, 2026 9:39 PM ET7/31/26•Somewhat-Bullish

KZR Competitors

Company	Ticker
Fractyl Health, Inc. Common Stock	GUTS
DarioHealth Corp	DRIO
Gossamer Bio Inc	GOSS
Kalaris Therapeutics, Inc.	KLRS
Pliant Therapeutics Inc	PLRX
Inspira Technologies Oxy BHN Ltd	IINN
Talphera Inc.	TLPH
Mink Therapeutics Inc	INKT

Sector: Healthcare

KZR Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: -120.6%
EPS estimate (fiscal period ending Jun 30, 2026): $-0.91
Estimate revisions (30 days, fiscal period ending Jun 30, 2026): 1 up, 0 down

Frequently Asked Questions About KZR

Does KZR pay dividends?

Kezar Life Sciences Inc (KZR) does not currently pay a regular dividend.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In